ÇİÇİN, İ. Et Al. 2017. Characteristics of Turkish colorectal cancer patients and bevacizumab preference.. ESMO 2017 , (Madrid, Spain).

ÇİÇİN, İ., GÜMÜŞ, M., UNCU, D., ÖZKAN, M., KILIÇKAP, S., ELKIRAN, E. T., ... IŞIKDOĞAN, A.(2017). Characteristics of Turkish colorectal cancer patients and bevacizumab preference. . ESMO 2017, Madrid, Spain

ÇİÇİN, İRFAN Et Al. "Characteristics of Turkish colorectal cancer patients and bevacizumab preference.," ESMO 2017, Madrid, Spain, 2017

ÇİÇİN, İRFAN Et Al. "Characteristics of Turkish colorectal cancer patients and bevacizumab preference.." ESMO 2017 , Madrid, Spain, 2017

ÇİÇİN, İ. Et Al. (2017) . "Characteristics of Turkish colorectal cancer patients and bevacizumab preference.." ESMO 2017 , Madrid, Spain.

@conferencepaper{conferencepaper, author={İRFAN ÇİÇİN Et Al. }, title={Characteristics of Turkish colorectal cancer patients and bevacizumab preference.}, congress name={ESMO 2017}, city={Madrid}, country={Spain}, year={2017}}